Extract from the Register of European Patents

EP About this file: EP0745330

EP0745330 - Anti-regurgitation infant formula [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  29.09.2006
Database last updated on 11.04.2026
Most recent event   Tooltip29.09.2006Revocation of patentpublished on 02.11.2006  [2006/44]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [1996/49]For all designated states
Bristol-Myers Squibb Company
345 Park Avenue
New York, N.Y. 10154 / US
Inventor(s)01 / Martinez, Sarah B.
3388 Avondale Drive
Newburgh, IN 47630 / US
[1996/49]
Representative(s)Adams, Harvey Vaughan John, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2001/22]Adams, Harvey Vaughan John, et al
Mathys & Squire, 100 Gray's Inn Road
London WC1X 8AL / GB
Former [2000/24]Ritter, Stephen David, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL / GB
Former [1996/49]Mays, Julie
Bristol-Myers Squibb Company Limited, Patent Department, Swakeleys House, Milton Road
Ickenham, Uxbridge UB10 8NS / GB
Application number, filing date96201526.931.05.1996
[1996/49]
Priority number, dateUS1995045769901.06.1995         Original published format: US 457699
[1996/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0745330
Date:04.12.1996
Language:EN
[1996/49]
Type: B1 Patent specification 
No.:EP0745330
Date:07.10.1998
Language:EN
[1998/41]
Search report(s)(Supplementary) European search report - dispatched on:EP27.09.1996
ClassificationIPC:A23L1/0522
[1996/49]
CPC:
A23L33/19 (EP,US); A23L29/212 (EP,US); A23L33/12 (EP,US);
A23L33/40 (EP,US); A61P1/08 (EP); A23V2002/00 (EP,US);
Y10S426/801 (EP,US) (-)
C-Set:
A23V2002/00, A23V2200/242, A23V2250/5118, A23V2250/5102 (US,EP);
A23V2002/00, A23V2250/5118 (US,EP);
A23V2002/00, A23V2250/5118, A23V2250/5102, A23V2250/70 (EP,US);
A23V2002/00, A23V2250/5424, A23V2250/54252, A23V2250/5488, A23V2250/18, A23V2250/188, A23V2250/612, A23V2250/5118, A23V2250/5102 (US,EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/49]
TitleGerman:Säuglingsnahrung gegen Erbrechen[1996/49]
English:Anti-regurgitation infant formula[1996/49]
French:Nourriture anti-régurgitation pour enfants[1996/49]
Examination procedure23.01.1997Examination requested  [1997/17]
23.01.1997Request for accelerated examination filed
09.04.1997Despatch of a communication from the examining division (Time limit: M04)
09.04.1997Decision about request for accelerated examination - accepted: Yes
08.08.1997Reply to a communication from the examining division
08.10.1997Despatch of communication of intention to grant (Approval: Yes)
27.01.1998Communication of intention to grant the patent
09.03.1998Fee for grant paid
09.03.1998Fee for publishing/printing paid
Divisional application(s)EP97203617.2  / EP0846422
Opposition(s)Opponent(s)01  06.07.1999  16.07.1999  ADMISSIBLE
NESTEC S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Straus, Alexander
Patentanwälte
Becker, Kurig, Straus
Bavariastrasse 7
80336 München / DE
 02  06.07.1999  16.07.1999  ADMISSIBLE
Wyeth
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Opponent's representative
Mannion, Sally Kim
Wyeth Laboratories
Huntercombe Lane South
Taplow
Maidenhead
Berkshire SL6 0PH / GB
 [N/P]
Former [2002/26]
Opponent(s)01  06.07.1999  16.07.1999  ADMISSIBLE
NESTEC S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Straus, Alexander, Dr. Dipl.-Chem.
Patentanwälte Becker, Kurig, Straus Bavariastrasse 7
80336 München / DE
 02  06.07.1999  16.07.1999  ADMISSIBLE
Wyeth
Five Giralda Farms
Madison, New Jersey 07940 0874 / US
Opponent's representative
Mannion, Sally Kim, Dr.
c/o Wyeth Laboratories, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 0PH / GB
Former [2001/25]
Opponent(s)01  06.07.1999  16.07.1999  ADMISSIBLE
NESTEC S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Straus, Alexander, Dr. Dipl.-Chem.
Patentanwälte Becker, Kurig, Straus Bavariastrasse 7
80336 München / DE
 02  06.07.1999  16.07.1999  ADMISSIBLE
American Home Products Corporation
Five Giralda Farms
Madison, New Jersey 07940 0874 / US
Opponent's representative
Mannion, Sally Kim, Dr.
c/o Wyeth Laboratories, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 0PH / GB
Former [1999/34]
Opponent(s)01  06.07.1999  16.07.1999  ADMISSIBLE
NESTEC S.A.
Avenue Nestlé 55
1800 Vevey / CH
 02  06.07.1999  16.07.1999  ADMISSIBLE
American Home Products Corporation
Five Giralda Farms
Madison, New Jersey 07940 0874 / US
Opponent's representative
Mannion, Sally Kim, Dr.
c/o Wyeth Laboratories, Huntercombe Lane South, Taplow
Maidenhead, Berkshire SL6 0PH / GB
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
15.10.1999Invitation to proprietor to file observations on the notice of opposition
02.06.2000Reply of patent proprietor to notice(s) of opposition
15.11.2001Date of oral proceedings
01.03.2002Despatch of minutes of oral proceedings
01.03.2002Date of despatch of rejection of opposition
20.04.2006Despatch of communication that the patent will be revoked
24.04.2006Legal effect of revocation of patent [2006/44]
Appeal following opposition26.04.2002Appeal received No.  T0424/02
10.07.2002Statement of grounds filed
11.09.2006Interlocutory revision of appeal
11.09.2006Result of appeal procedure: revocation of the patent
20.04.2006Date of oral proceedings
03.05.2006Minutes of the oral proceedings despatched
Fees paidRenewal fee
11.05.1998Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU31.05.1999
MC30.11.1999
[2004/39]
Former [2003/18]MC30.11.1999
Former [2003/17]MC31.05.1999
Former [2000/25]MC30.11.1999
Documents cited:Search[XY] US4140760  (WITHINGTON ROGER et al.)
 [XY] US3539358  (HING FRANCISCO S et al.) [X] 1 * column 3 * * example 14 *[Y] 1-28
 [X] SU1729404   [X] 1 * column 5, line 43 * * column 2, line 56 - line 66 * * column 1, line 19 - line 25 *
 [X] US4428972  (WURZBURG OTTO B et al.)
 [Y] GB1220838  (AVEBE COOP VERKOOP PROD et al.) [Y] 1-28 * column 3, line 11 - line 20 * * column 2, line 24 - line 31 *
 [X]   DATABASE WPI Section Ch Week 9315, Derwent World Patents Index; Class D12, AN 93-124523, XP002010925 [X] 1 * column 5, line 43 * * column 2, line 56 - line 66 * * column 1, line 19 - line 25 *
Examination  EU Commision Directive of 14 May 1991 on infant formulae and follow-on formulae
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.